The complex relation between bisphosphonate adherence and fracture reduction.
about
Novel advances in the treatment of osteoporosis.Medication (re)fill adherence measures derived from pharmacy claims data in older Americans: a review of the literature.Potential and pitfalls of using large administrative claims data to study the safety of osteoporosis therapies.Challenges in implementing and maintaining osteoporosis therapy.The potential economic benefits of improved postfracture care: a cost-effectiveness analysis of a fracture liaison service in the US health-care system.Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.A practical approach to osteoporosis management in the geriatric populationOsteoporosis in men: insights for the clinicianDiagnosis and treatment of osteoporosis in high-risk patients prior to hip fractureBisphosphonates adherence for treatment of osteoporosis.Association between gastrointestinal events and compliance with osteoporosis therapy.Clinical experience with intravenous zoledronic acid in the treatment of male osteoporosis: evidence and opinionsCost-effectiveness of bone densitometry among Caucasian women and men without a prior fracture according to age and body weight.Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trialAlendronate versus Raloxifene for Postmenopausal Women: A Meta-Analysis of Seven Head-to-Head Randomized Controlled Trials.Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis.Adherence with medications used to treat osteoporosis: behavioral insights.Non-adherence with bisphosphonates among patients with osteoporosis: impact on fracture risk and healthcare cost.Use of pharmacy records to measure treatment adherence: a critical review of the literature.Composite Hydrogels for Bone RegenerationCompliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: a randomised controlled trial of specialist vs. non-specialist management.Predictors of re-fracture amongst patients managed within a secondary fracture prevention program: a 7-year prospective study.Evaluation of a program of integrated care to reduce recurrent osteoporotic fractures.Assessment of geriatric predictors of adherence to Zoledronic acid treatment for osteoporosis: a prospective follow-up study.Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates.How the knowledge of fracture risk might influence adherence to oral therapy of osteoporosis in Italy: the ADEOST study.The challenges of diagnosing osteoporosis and the limitations of currently available tools.
P2860
Q30248319-FCACFD13-39CB-4314-878F-1C2AACC30A64Q30611728-F0AAE479-0A36-4DBA-A2A7-FB09A9F9F592Q33818302-090DAA26-4931-4543-B3F8-7831F1AFADB3Q34073740-04CFB0BB-0EC6-4C0B-9CBA-494F50CF2026Q34251696-0C73CC56-6FA8-44FB-AB85-E39D4C0A7118Q34440107-AC8D1C37-93C9-446A-AA1A-A6C4FF88C5FFQ35223327-80951C10-1AAC-4202-B43A-422C131E590FQ36056965-0D088F75-5B9D-4FD8-A397-ECF46D744264Q36686995-2DB69288-7228-4855-A7D5-C8A7078F0FDFQ36908527-4027EE17-D79E-471A-9C8C-478224CC51EDQ37051660-4EACBF60-8C65-4E50-888A-FEFE1FE2DCADQ37058784-75E4B564-035F-4D11-B7A3-0D73A0FFEC68Q37085615-6643008D-C3E5-4D45-88F8-D6A01228A83FQ37528565-9A591543-8014-4ED2-8E0B-80CECB3580B7Q37551824-78168F6B-9CF0-4DE1-9C5F-FDB5ABEB8F5BQ38029296-913AF291-7CB0-47DC-9C80-3F4F47E93214Q38075457-345AF1DC-C57C-47F0-8924-3C80C726E134Q38788967-C19C19F3-4E9D-471E-BF01-68A953E36778Q38819475-41F37FBD-9B3D-4855-8564-6C8DCE1E2F9DQ38887763-6F49EFDE-47F7-416C-A04A-901B5D1C53C0Q44220925-F664DAE2-9D15-4E1D-BF29-9810844F1459Q45280883-EBD5DA8D-F8FA-4FC8-A7E2-0421E3AE3AD8Q46356238-DBE9A186-346E-44A5-97E9-A8C94FCA1764Q47563434-38BAAEBB-CA22-4E5C-8C43-2FED1D00395CQ49630595-40EAD3DB-17A1-4383-B733-3D7A0827C880Q50533723-2A41BAD4-778F-4260-B778-039CAEAB5552Q55113719-AFE3861E-8FF9-4BAD-8C4D-DEDE8BF8A261
P2860
The complex relation between bisphosphonate adherence and fracture reduction.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The complex relation between bisphosphonate adherence and fracture reduction.
@ast
The complex relation between bisphosphonate adherence and fracture reduction.
@en
The complex relation between bisphosphonate adherence and fracture reduction.
@nl
type
label
The complex relation between bisphosphonate adherence and fracture reduction.
@ast
The complex relation between bisphosphonate adherence and fracture reduction.
@en
The complex relation between bisphosphonate adherence and fracture reduction.
@nl
prefLabel
The complex relation between bisphosphonate adherence and fracture reduction.
@ast
The complex relation between bisphosphonate adherence and fracture reduction.
@en
The complex relation between bisphosphonate adherence and fracture reduction.
@nl
P2093
P2860
P356
P1476
The complex relation between bisphosphonate adherence and fracture reduction.
@en
P2093
Amanda R Patrick
Daniel H Solomon
Helen Mogun
John T Schousboe
M Alan Brookhart
Suzanne M Cadarette
P2860
P304
P356
10.1210/JC.2009-2778
P407
P50
P577
2010-05-05T00:00:00Z